ABSTRACT
Finally, it has been suggested that the recurrence rate following successful recanalization of chronic occlusions is predominantly determined by the occurrence of early reocclusion.32 Therefore, the additional value of a routine use of peri-procedural adjunctive medication, including potent platelet aggregation blocking agents (e.g. abciximab), followed by clopidogrel during the early follow-up period, needs to be assessed in a prospective study.
